Federal Signal Supports MVM's NEUBIE Launch: A Breakthrough in Veteran Care
- MVM's NEUBIE device, available through Federal Supply Schedule, enhances neuromuscular re-education for veterans.
- NEUBIE is FDA-cleared for various medical conditions, improving veterans' recovery and quality of life.
- MVM's status as a Service-Disabled Veteran-Owned Small Business emphasizes its commitment to veteran-centric healthcare solutions.
Transforming Veteran Care: The Launch of NEUBIE by Maness Veteran Medical
Maness Veteran Medical (MVM) introduces the NEUBIE (Neuro-Bio-Electric Stimulator), a groundbreaking device designed to enhance neuromuscular re-education for veterans, now available through the Federal Supply Schedule under contract 36F79725D0083. This innovative, non-invasive electrical stimulation device stands out for its use of direct current (DC), which distinguishes it from traditional alternating current (AC) stimulators. By leveraging the body's natural healing processes, the NEUBIE aims to restore healthy neuromuscular patterns, offering significant hope to veterans grappling with various medical conditions. With the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) healthcare providers now able to access this technology across the nation, MVM demonstrates its commitment to enhancing veteran care.
The NEUBIE device is FDA-cleared for a range of indications, including neuromuscular re-education, pain relief, post-surgical rehabilitation, and improved local blood circulation. Real-world applications of the NEUBIE showcase its potential to alleviate conditions commonly experienced by veterans, such as diabetic neuropathy and phantom limb pain. For instance, the success story of a U.S. Army Special Forces Green Beret named Kaleb highlights the device's capabilities; after suffering a spinal injury, he regained lost functionality through targeted rehabilitation using the NEUBIE. Such outcomes not only emphasize the efficacy of this advanced technology but also signify a broader commitment to supporting veterans in overcoming pain and trauma.
MVM’s launch of the NEUBIE is a pivotal development in the field of veteran healthcare, as it combines cutting-edge technology with a mission-driven approach. The device represents a "highway to healing" for veterans, facilitating recovery processes that can significantly improve their quality of life. MVM’s focus on innovative solutions that prioritize the well-being of veterans reflects a growing recognition of the unique challenges faced by this population. As the NEUBIE becomes integrated into veterans' care plans, it stands to redefine recovery strategies within the military healthcare system.
In addition to the NEUBIE launch, MVM’s accreditation as a Service-Disabled Veteran-Owned Small Business positions it uniquely within the industry. This status not only enhances credibility but also underscores a commitment to serving fellow veterans. The prioritization of veteran-centric solutions is becoming increasingly critical in healthcare, and MVM's initiatives highlight the potential for transformative advancements in this sector. With the NEUBIE, MVM reinforces its dedication to the mission of supporting those who have served their country, ensuring they receive the best possible care.
Related Cashu News

Lockheed Martin Advances AI, Autonomy, and Space Exploration for Enhanced Military Operations and Safety
Lockheed Martin (Ticker: LMT) is making significant strides in integrating artificial intelligence and autonomy to enhance the efficiency and safety of military operations. The company focuses on deve…

AeroVironment Reports 133% Revenue Growth Amid Rising Military Demand for UAVs
AeroVironment (Ticker: AVAV) has emerged as a leader in the unmanned aerial vehicle (UAV) industry, particularly amidst a heightened global focus on defense technologies. The company has achieved subs…

AZZ Inc. Earnings Report Could Impact Stock Volatility and Dividend Investor Sentiment
AZZ Inc. (Ticker: AZZ) positions itself strongly in the industrial sector with its upcoming earnings report, reflecting its financial health and dividend strategy. Scheduled for release on July 8, the…

Astronics Signs Long-Term Deal with Vertical Aerospace for Valo eVTOL Power Systems
In late June 2026, Vertical Aerospace establishes a long-term agreement with Astronics Corporation (Ticker: ATRO) to supply the low-voltage power distribution system for its Valo eVTOL aircraft. This…

